P. Martin

发表

Growth factors and oncogenes.

Y. Berthois, P. Martin, 1989, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

SR31747A is a sigma receptor ligand exhibiting antitumoural activity both in vitro and in vivo

S. Galiègue, P. Casellas, P. Carayon, 2003, British Journal of Cancer.

The protein kinase C-η isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway

I. Hussaini, R M Uht, S Amos, 2007, Oncogene.

Cell-cycle studies by multiparametric automatic scanning of topographically preserved cells in culture.

F. Spyratos, P. Martin, E. Colomb, 1989, Cytometry.

Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.

L. Ouafik, P. Rocchi, X. Muracciole, 2001, Cancer research.

Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells.

J. Jacquemier, P. Rolland, P. Martin, 1980, Journal of the National Cancer Institute.

Comparative study of four extraction procedures for urokinase type plasminogen activator and plasminogen activator inhibitor-1 in breast cancer tissues.

F. Spyratos, S. Romain, H. Magdelenat, 1995, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

Impact of menopausal hormone‐replacement therapy on clinical and laboratory characteristics of breast cancer

A. Sasco, S. Romain, P. Bonnier, 1998, International journal of cancer.

Prognostic value of cytosolic tyrosine kinase activity in 249 node-positive breast cancer patients.

J. Foekens, J. Klijn, M. Look, 1994, British Journal of Cancer.

Influence of pregnancy on the outcome of breast cancer: A case‐control study

J. Julien, S. Romain, P. Bonnier, 1997, International journal of cancer.

Human breast cancer cells share antigens with the myeloid monocyte lineage.

P. de Cremoux, H. Magdelenat, F. Calvo, 1987, British Journal of Cancer.

A multiparametric analysis of endometrial estrogen and progesterone receptors after the postovulatory administration of mifepristone.

D. Cornet, Y. Berthois, P. Martin, 1991, Fertility and sterility.

Somatostatin and opioid receptors in mammary tissue. Role in cancer cell growth.

E. Castanas, A. Hatzoglou, S. Loukas, 2000, Advances in experimental medicine and biology.

Modulation of the estrogen‐regulated proteins cathepsin D and pS2 by opioid agonists in hormone‐sensitive breast cancer cell lines (MCF7 and T47D): Evidence for an interaction between the two systems

E. Castanas, F. Calvo, A. Hatzoglou, 1998, Journal of cellular biochemistry.

Laminin expression by two clones isolated from the colon carcinoma cell line lovo that differ in metastatic potential and basement‐membrane organization

J. Lissitzky, J. Doré, C. Bignon, 1992, International journal of cancer.

Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors.

E. Castanas, A. Hatzoglou, A. Damianaki, 1997, European journal of pharmacology.

Relationship of stromal elastosis to steroid receptors in human breast carcinoma.

P. Martin, J. Jacquemier, R. Lieutaud, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Concomitant Secretion by A431 Cells of Tissue Plasminogen Activator and a Specific Inhibitor Masks EGF Modulation of tPA Activity

J. Sampol, Y. Berthois, P. Martin, 1990, Thrombosis and Haemostasis.

Radioligand purification prior to routine receptor assays.

Y. Berthois, P. Martin, J. Le Goff, 1988, Journal of steroid biochemistry.

Progestin and oestrogen receptors in meningiomas. Biochemical characterization, clinical and pathological correlations in 42 cases

A. Buge, H. Magdelenat, J. Philippon, 2005, Acta Neurochirurgica.

Modulable Southern and Northern blot hybridization apparatus for routine screening of gene amplification and expression.

J. Lissitzky, C. Bignon, P. Martin, 1990, Journal of biochemical and biophysical methods.

Regulation of p42 mitogen-activated-protein kinase activity by protein phosphatase 2A under conditions of growth inhibition by epidermal growth factor in A431 cells.

C. Cochet, Y. Berthois, P. Martin, 1996, European journal of biochemistry.

Laminin biosynthesis in the extracellular matrix-producing cell line PFHR9 studied with monoclonal and polyclonal antibodies.

J. Lissitzky, C. Bignon, C. Charpin, 1988, The Biochemical journal.

[Laser therapy in the prevention and treatment of mucositis caused by anticancer chemotherapy].

M. Namer, F. Demard, M. Soudry, 1992, Bulletin du cancer.

Estradiol membrane binding sites on human breast cancer cell lines. Use of a fluorescent estradiol conjugate to demonstrate plasma membrane binding systems.

Y. Berthois, P. Martin, N. Tubiana, 1986, Journal of steroid biochemistry.

Binding of antiestrogens exposes an occult antigenic determinant in the human estrogen receptor.

E. Jensen, Y. Berthois, P. Martin, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Human benign breast disease: relationships between prostaglandin E2, steroid hormones, and thermographic effects of the inhibitors of PG biosynthesis.

P. Rolland, P. Martin, A. M. Rolland, 1980, Advances in prostaglandin and thromboxane research.

Benign Breast Disease: Studies of Prostaglandin E2, Steroids, and Thermographic Effects of Inhibitors of Prostaglandin Biosynthesis

P. Rolland, P. Martin, A. M. Rolland, 1979, Obstetrics and gynecology.

Studies on clinical, hormonal and pathological correlations in breast fibroadenomas.

P. Martin, F. Kuttenn, P. Mauvais-Jarvis, 1978, Journal of steroid biochemistry.

PNU 157706, a novel dual type I and II5α-reductase inhibitor

A. Panzeri, A. Radice, P. Martin, 1998, The Journal of Steroid Biochemistry and Molecular Biology.

cDNA cloning and genomic analysis of a new multigene family sharing common phylogenetic and expression profiles with the laminin receptor gene.

M. Wicha, C. Bignon, P. Martin, 1992, Biochemical and biophysical research communications.

Genomic analysis of the 67-kDa laminin receptor in normal and pathological tissues: circumstantial evidence for retroposon features.

M. Wicha, M. Mattei, J. Lissitzky, 1991, Genomics.

Relationships between steroid receptor and epithelial cell proliferation in benign fibrocystic disease of the breast

J. Jacquemier, P. Rolland, P. Martin, 1982, Cancer.

Spontaneous canine mammary tumour: a model for human endocrine therapy?

J. Raynaud, P. Rolland, F. André, 1981, Journal of steroid biochemistry.

Soft-laser therapy for iatrogenic mucositis in cancer patients receiving high-dose fluorouracil: a preliminary report.

M. Namer, F. Demard, P. Chauvel, 1992, Journal of the National Cancer Institute.

[Steroid receptors in the central nervous system. Implications in neurology].

H. Magdelenat, M. Poisson, P. Martin, 1984, Revue neurologique.

Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancer.

O. Chinot, I. Christensen, I. Balslev, 1995, International journal of cancer.

Unbound progesterone receptors are in equilibrium between the nucleus and cytoplasm in cells of the rat uterus.

P. Sheridan, P. Martin, J. Buchanan, 1981, Endocrinology.

Subcellular compartmentalization of estrogen receptors in human breast cancer cells.

D. Edwards, W. McGuire, K. Horwitz, 1980, Experimental cell research.

Prostaglandin production and metabolism in human breast cancer.

J. Jacquemier, P. Rolland, P. Martin, 1980, Advances in prostaglandin and thromboxane research.

Macromolecular binding of dexamethasone as evidence for the presence of mineralocorticoid receptor in human breast cancer.

J. Raynaud, P. Rolland, P. Martin, 1981, Cancer research.

[Immunohistochemical study using monoclonal antibodies (H222 SP gamma) of estrogen receptors: correlation with biochemical analysis (by radioligand) of 115 breast carcinomas].

J. Jacquemier, C. Charpin, P. Martin, 1986, Bulletin du cancer.

A preliminary report on the use of immunoperoxidases to study binding of estrogens in rat uteri.

P. Rolland, P. Martin, F. Kopp, 1979, Journal of steroid biochemistry.

Relationship between the MAP kinase activity and the dual effect of EGF on A431 cell proliferation.

G. Pagès, C. Cochet, K. Afdel, 1994, Biochemical and biophysical research communications.

Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.

S. Saez, P. Martin, C. Chouvet, 1978, Cancer research.

Molecular profile of androgen-independent prostate cancer xenograft LuCaP 23.1

L. Ouafik, P. Rocchi, I. Nanni-Metellus, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

Mode of EGF action on cell cycle kinetics in human breast cancer cell line MCF-7: some evidence that EGF acts as a "progression factor".

D. Isnardon, X. F. Dong, J. Palmari, 1992, Anticancer Research.

Multiparametric prognostic evaluation of biological factors in primary breast cancer.

F. Spyratos, S. Romain, V. Le Doussal, 1992, Journal of the National Cancer Institute.

Biological heterogeneity of er‐positive breast cancers in the post‐menopausal population

O. Chinot, S. Romain, P. Martin, 1994, International journal of cancer.

Technical evaluation of thymidine kinase assay in cytosols from breast cancers. EORTC Receptor Study Group Report.

O. Chinot, F. Spyratos, S. Romain, 1994, European journal of cancer.

Estrogen response of MCF-7 cells grown on diverse substrates and in suspension culture: promotion of morphological heterogeneity, modulation of progestin receptor induction; cell-substrate interactions on collagen gels.

J. Jacquemier, C. Charpin, Y. Berthois, 1984, Journal of steroid biochemistry.

Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.

A. Desplaces, K. Hacène, P. Martin, 1991, British Journal of Cancer.

[Modification of growth dynamics and ultrastructure of human gingival fibroblasts after treatment with an helium-neon-laser].

J C Franquin, M. Soudry, P M Martin, 1989, Die Quintessenz.

Fluorescence-based assay of estrogen receptor using 12-oxo-9(11)-dehydroestradiol-17 beta.

J. Katzenellenbogen, K. Carlson, H. Magdelenat, 1986, Analytical biochemistry.

A minimal model for calcium signal generated by tyrosine kinase and G protein linked receptors; a stochastic computer simulation with CALSIM.

C. Penel, J. Palmari, Y. Berthois, 1997, International journal of medical informatics.

Evidence of estrogen receptors in the trigone area of human urinary bladder.

S. Saez, P. Martin, 1981, Journal of steroid biochemistry.

A differential nuclear uptake and retention of 3H-androgens in the thyroids of baboons

R. Triplett, G. Holt, P. Sheridan, 1988, Journal of endocrinological investigation.

Estrogen receptor immunocytochemical assay (ER-ICA): computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas.

J. Jacquemier, C. Charpin, P. Martin, 1986, Cancer research.

Towards a new model for the mechanism of action of steroids.

P. Sheridan, P. Martin, Pierri M. Martin, 1982, Journal of steroid biochemistry.

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas.

F. Spyratos, K. Hacène, P. Martin, 1994, British Journal of Cancer.

Laminin distribution in human decidua and immature placenta. An immunoelectron microscopic study (avidin-biotin-peroxidase complex method).

J. Lissitzky, C. Charpin, P. Martin, 1985, American journal of obstetrics and gynecology.

Correlation of erbB-2 gene amplification with low levels of estrogen and/or progesterone receptors in primary breast cancer: do erbB-2 products delineate hormone-independent tumors?

S. Romain, N. Dussault, P. Martin, 1989, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

How culture conditions modulate the morphofunctional differentiation of the human estradiol-sensitive mammary cell line (MCF-7).

S. Nandi, J. Jacquemier, C. Charpin, 1984, Journal of steroid biochemistry.

Immunohistochemical detection of laminin in 98 human breast carcinomas: a light and electron microscopic study.

J. Lissitzky, J. Jacquemier, C. Charpin, 1986, Human pathology.

Estrogen Receptor Immunocytochemical Assay (ER-ICA) and Laminin Detection in 115 Breast Carcinomas: A Light and Electron Microscopy Study with a Computerized (Samba 200) Quantitative Analysis on Tissue Sections

J. Jacquemier, C. Charpin, P. Martin, 1986 .

Progesterone receptors in breast fibroadenomas.

P. Martin, F. Kuttenn, P. Mauvais-Jarvis, 1979, Journal of steroid biochemistry.

Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta

T. Sturgill, I. Hussaini, C. Chrestensen, 2007, Oncogene.

Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients.

B Asselain, P Broët, B. Asselain, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A nomogram to predict individual prognosis in node-negative breast carcinoma.

F. Spyratos, S. Romain, C. Mazouni, 2012, European journal of cancer.

[Determination of estrogen receptors in 160 breast tumors using monoclonal antibodies: comparison of Abbott's immunoenzymatic method with the carbon dextran method].

P. Martin, J. Goussard, C. Lechevrel, 1985, Bulletin du cancer.

Androblastoma: Pre-, per- and post-operative steroid hormone and binding protein concentrations in peripheral plasma, cyst fluid and tumor vein

P. Rolland, F. Laffargue, P. Martin, 1981, Journal of endocrinological investigation.

Differential dose-dependent effects of epidermal growth factor on gene expression in A431 cells: evidence for a signal transduction pathway that can bypass Raf-1 activation.

M. Silvy, Y. Berthois, P. Martin, 1998, Endocrinology.

c-myc gene amplification in selected node-negative breast cancer patients correlates with high rate of early relapse.

S. Romain, P. Bonnier, N. Dussault, 1992, European journal of cancer.

A paradigm for oncogene complementation in human breast cancer.

P. Martin, M. Roux-Dosseto, 1989, Research in virology.

Routine analysis of multiple steroid receptors in human breast cancer.--I--Technological features.

J. Jacquemier, P. Rolland, P. Martin, 1978, Biomedicine / [publiee pour l'A.A.I.C.I.G.].

Multiple steroid receptors in human breast cancer

J. Jacquemier, P. Rolland, P. Martin, 1979, Cancer Chemotherapy and Pharmacology.

Multiple steroid receptors in human breast cancer

J. Jacquemier, P. Rolland, P. Martin, 2004, Cancer Chemotherapy and Pharmacology.

Frequency and genome load of Epstein-Barr virus in 509 breast cancers from different geographical areas

F. Spyratos, J. Seigneurin, M. Buisson, 2001, British Journal of Cancer.

Phytoestrogen interaction with estrogen receptors in human breast cancer cells.

W. McGuire, K. Horwitz, W L McGuire, 1978, Endocrinology.

Intracellular distribution of estrogen receptors: A function of preparation

P. Sheridan, P. Martin, 1980, Experientia.

Determination of oestrogen receptors: application of the Passing-Bablock linear regression technique for comparison of enzyme immunoassay and radioligand binding assay in 1841 breast cancer tumours.

S. Romain, C. Dussert, P. Martin, 1991, European journal of cancer.

Prognostic factor clustering in breast cancer: biology or chronology?

F. Spyratos, K. Hacène, P. Martin, 1995, European journal of cancer.

Regulation of epidermal growth factor-receptor by estrogen and antiestrogen in the human breast cancer cell line MCF-7.

X. F. Dong, Y. Berthois, P. Martin, 1989, Biochemical and biophysical research communications.

The primate thyroid gland contains receptors for androgens.

H. Mcgill, J. Lissitzky, P. Sheridan, 1984, Endocrinology.

Dissemination risk index based on plasminogen activator system components in primary breast cancer.

V. Bécette, F. Spyratos, K. Hacène, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Prostaglandins and cancer of the breast (author's transl)].

P. Rolland, P. Martin, 1981, Journal de gynecologie, obstetrique et biologie de la reproduction.

Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.

D. Blangy, K. Drieu, C. Neri, 1990, Cancer research.

Current and Emerging Targeting Strategies for Treatment of Pancreatic Cancer.

A. Baines, P. Martin, C. J. Rorie, 2016, Progress in molecular biology and translational science.

Helium-neon laser treatment transforms fibroblasts into myofibroblasts.

J C Franquin, J. Jacquemier, M. Soudry, 1990, The American journal of pathology.

Simultaneous quantitative detection of relevant biomarkers in breast cancer by quantitative real-time PCR.

A. Schaller, S. Eppenberger-Castori, U. Eppenberger, 2006, The International journal of biological markers.

Antagonism by suramin of the growth-inhibitory effect of hydroxytamoxifen and doxorubicin in human MCF-7 breast cancer cells.

X. F. Dong, E. Cvitkovic, Y. Berthois, 1992, Journal of the National Cancer Institute.

S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study.

M. Bolla, F. Spyratos, S. Romain, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Clinical and Biologic Prognostic Factors in Breast Cancer Diagnosed During Postmenopausal Hormone Replacement Therapy

S. Romain, P. Bonnier, P. Martin, 1995, Obstetrics and gynecology.

Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group.

S. Romain, H. Magdelenat, P. Martin, 1995, European journal of cancer.

Determination of oestrogen receptors by enzyme immunoassay. Technical differences between laboratories and their consequences.

G. Milano, S. Romain, M. Francoual, 1994, European journal of cancer.

Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.

J. Foekens, J. Klijn, S. Romain, 2001, Cancer research.

Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols.

P. Martin, J. Goussard, C. Lechevrel, 1986, Cancer research.

Monoclonal antibodies for progesterone receptor assays and polymorphism studies in breast cancer. Comparison with radioligand assays.

H. Magdelenat, P. Martin, J. Goussard, 1988, Bulletin du cancer.

Reliability and discriminant validity of HER2 gene quantification and chromosome 17 aneusomy analysis by real-time PCR in primary breast cancer.

P. Lamy, S. Romain, L. Ouafik, 2006, The International journal of biological markers.

Laminin immunodetection in tumorous and nontumorous disorders of human thyroid.

J. Lissitzky, C. Charpin, P. Martin, 1985, Bulletin du cancer.

DNA‐synthesizing enzymes in breast cancer (thymidine kinase, thymidylate synthase and thymidylate kinase): Association with flow cytometric s‐phase fraction and relative prognostic importance in node‐negative premenopausal patients

M. Fernö, P. Bendahl, S. Romain, 2001, International journal of cancer.

DNA-SYNTHESIZIN GENZYME SI NBREAS TCANCE R(THYMIDIN EKINASE, THYMIDYLAT ESYNTHAS EAN DTHYMIDYLAT EKINASE) :ASSOCIATION WIT HFLO WCYTOMETRI CS-PHAS EFRACTIO NAN DRELATIV EPROGNOSTIC IMPORTANC EI NNODE-NEGATIV EPREMENOPAUSA LPATIENTS

P. Bendahl, S. Romain, P. Martin, 2001 .

Nuclear texture parameters as discriminant factors in cell cycle and drug sensitivity studies.

C. Dussert, P. Martin, E. Colomb, 1991, Cytometry.

The effect of intrauterine contraceptive devices on ovarian and menstrual function in the human.

J. Brown, P. Martin, 1973, The Journal of clinical endocrinology and metabolism.

Mutation analysis in the coding sequence of thymidine kinase 1 in breast and colorectal cancer.

S. Galiègue, P. Casellas, S. Romain, 2003, The International journal of biological markers.

Multiparametric study (SAMBA 200) of estrogen receptor immunocytochemical assay in 400 human breast carcinomas: analysis of estrogen receptor distribution heterogeneity in tissues and correlations with dextran coated charcoal assays and morphological data.

L. Andrac, C. Charpin, C Charpin, 1988, Cancer research.

Distinct effects of gonadotropin-releasing hormone analogs and 4-hydroxytamoxifen on pS2 mRNA expression with respect to cell proliferation in MCF-7 breast cancer cells.

C. Neri, P. Martin, E. Colomb, 1991, Anticancer research.

Estradiol 17 beta-hydroxysteroid dehydrogenase, a marker of breast cancer hormone dependency.

P. Martin, F. Kuttenn, P. Mauvais-Jarvis, 1985, Cancer research.

New approach for visualizing estrogen receptors in target cells using inherently fluorescent ligands and image intensification.

J. Katzenellenbogen, H. Magdelenat, P. Martin, 1983, Cancer research.

Exogenous amino acids regulate trophectoderm differentiation in the mouse blastocyst through an mTOR-dependent pathway.

A. Sutherland, Patrick M. Martin, P. Martin, 2001, Developmental biology.

[Effect of a helium-neon laser on cellular growth: an in vitro study of human gingival fibroblasts].

J C Franquin, M. Soudry, P M Martin, 1988, Journal de biologie buccale.

The place of hormone receptors in the elaboration of a therapeutic strategy against breast cancer.

H. Magdelenat, P. Pouillart, P. Martin, 1984, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[Human mammary carcinoma: relationship between steroid hormone receptors and histopathology. An hypothesis, the prognostic value of hormone receptors (author's transl)].

J. Jacquemier, P. Rolland, P. Martin, 1978, Bulletin du Cancer.

Cell cycle phase dependence of estrogen and epidermal growth factor (EGF) receptor expression in MCF-7 cells: implications in antiestrogen and EGF cell responsiveness.

X. F. Dong, Y. Berthois, P. Martin, 1991, Endocrinology.

Kappa casein, lactalbumin and GCDFP 70 localization in human breast carcinomas: An immunohistochemical study using the avidin-biotin-peroxidase complex method

J. Jacquemier, C. Charpin, P. Martin, 1985, Medical oncology and tumor pharmacotherapy.

[Cathepsin D: an independent prognostic factor in cancer of the breast].

C. Bressac, S. Romain, X. Muracciole, 1990, Bulletin du cancer.

Estradiol dependence of the specific mammary tissue targeting of polyoma virus oncogenicity in nude mice.

D. Blangy, M. Berebbi, Y. Berthois, 1990, Oncogene.

Quantification of oestradiol binding at the surface of human lymphocytes by flow cytofluorimetry.

J. Seigneurin, P. Martin, Y. Carcassonne, 1986, British Journal of Cancer.